Seoul, South Korea

Hye Ran Park

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Eyegene Inc.. Active years: 2009-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hye Ran Park. Retrieved from https://idiyas.com/inventor/hye-ran-park-a4ete4b7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2009-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hye Ran Park: Innovator in Immune Stimulating Compositions

Introduction

Hye Ran Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of immunology, particularly in the development of immune stimulating compositions. With a total of 2 patents, his work focuses on innovative solutions for cancer treatment.

Latest Patents

Hye Ran Park's latest patents include:

1. **Immune stimulating composition comprising bacterial chromosomal DNA fragments having methylated CpG sequences and non-toxic lipopolysaccharides**. This invention relates to a composition that can be industrially applied as effective materials for treating cancers and as an adjuvant.

2. **Immune stimulating and controlling composition comprising bacterial chromosomal DNA fragments and non-toxic lipopolysaccharides**. This patent also focuses on a composition that can be used for treating cancers and as an adjuvant.

Career Highlights

Hye Ran Park is currently associated with Eyegene Inc., where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in medical treatments.

Collaborations

Some of his notable coworkers include Bo Young Ahn and Yang Je Cho, who contribute to the collaborative efforts in their research projects.

Conclusion

Hye Ran Park's innovative work in immune stimulating compositions showcases his dedication to advancing medical science. His contributions have the potential to significantly impact cancer treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…